Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute, tapping into SCRI ...
Bristol Myers Squibb and Johnson & Johnson have stopped a phase 3 anticoagulant trial early for futility, closing off one avenue to market for a molecule tipped to generate multibillion-dollar sales.
The TV ad will run through Nov. 16 across major cable channels, including CNN, Fox News and ESPN, a BMS spokesperson told ...
BMS Stangeland will utilise it's ten new rough terrain cranes and five new all terrains from Sany across the Nordic region.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback